vca vet distribut contract loss news lose mln
annual revenu vet distribut contract larg custom vca privat
own mar reduc vet distribut rev mln given
contract transit increment mln
understand abc/ew via prior acquisit vet
distributor mwi like winner busi sinc mwi alreadi distribut
relationship parent mar via banfield oper anoth larg vet group
practic calcul could add annual ep
make chang model today final contract chang
involv big vet distribut competitor patterson pdco/uw total
manag note vca contract loss low margin estim
net margin materi busi earn henri schein
anim health total nevertheless trim ep
slightli conserv light revenu hit current street ep
total ep reduc street
remain co post vet spin-off see hypothet
earn power remov vet asset unchang relat vca news
impact feb time distribut spin-off still
seem track despit on-going govern shutdown impact
sec recent publish note detail analysi ahead vet spin-off
spin-off vca news would obvious impact revenu
earn impact still unclear suggest materi
henri schein anim health expect hear overal
financi pictur analyst meet feb current share price
total equat price-to-earnings revis ep theoret
appli price-to-earnings post-spin impli hypothet valuat post-
spin meantim still use price-to-earnings total today pt
quarterli annual ep usd
return equiti ttm
link barclay live interact chart
consensu number thomson reuter receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
equal weight compani manag well
face overal softer util differ
vertic help busi along howev
litig overhang threat amazon off-set
posit
upsid case result price-to-earnings multipl
expans modestli improv intern growth
util trend dental busi would
suggest compani take share and/or
underli market improv
downsid case see amazon
take share dental distributor
litig overhang caus custom demand
greater price concess could caus ep
growth slow mid singl digit multipl
summari detail spin
recent releas regulatori document relat pend henri schein
spin-off veterinari distribut aka anim health ah busi provid
detail financi analysi henri schein post-spin quick background figur
provid key detail regard transact note origin slate
spin-off compani recent privat sale transact
disclos recent amend holder expect
receiv undisclos proce recent sale transact
analysi henri schein remain co post-spin
base financi data recent file anim health asset
pledg includ hsic vet distribut segment portion
hsic technolog segment repres hsic total revenu
total ebitda confirm vet busi margin lower corpor averag
figur remov variou compon anim health distribut
anim health technolog busi core model forward basi
assum margin remain static remov model well note
transact expect close earli februari one month stub period
remain simplic purpos assum transact occur begin
collect ep reduc pre-spin post-spin
figur provid summari key metric compani pre post-spin
basi interestingli compani anim health busi drag total
compani profit margin ah busi seemingli less profit compar
core dental medic notabl remov anim health busi
declin gross margin ebit margin prior year core dental/med
busi slightli drastic given higher profit busi line
record share holder share holder addit sell sharehold total share ownership share share sell share per dividend detail spin-off barclay
 annual revenu model mil hsichsichsicreport revenu revenuena anim -- -- -- -- -- -- anim -- -- -- -- -- -- global anim -- -- -- -- -- -- na technology/valu ad revenu changena anim -- -- -- -- -- anim -- -- -- -- -- global anim -- -- -- -- -- na technology/valu ad revenuesna anim -- -- -- -- -- -- anim -- -- -- -- -- -- global anim -- -- -- -- -- -- na technology/valu ad barclay
 annual incom statement oper addback addback check ens rate interest earn affili check lineadj ep fulli dilut share line growth per share barclay
worth post-spin basi
one key question head transact stand-alone
worth gener believ investor place higher valuat multipl anim
health busi compar hsic core dental busi believ
transact consid special dividend paid
spin-off compani
immedi cash valu special dividend yield worth price-to-earnings point
import note expect receiv bln tax-fre proce
spin-off occur definit announc exact intent
proce like put toward share repurchas and/or debt paydown
analysi simpli divid cash proce estim share cash
would worth stock valu equat price-to-earnings point stock valuat
addit special dividend expect receiv cash proce recent
sell share unspecifi sharehold exact proce
disclos discuss compani suggest least cover
previous paid buy minor interest stake veterinari distribut
busi last year base amend file recent transact would reduc
sharehold ownership rang depend upon final term
sinc file investor note legaci vet busi seem
lower profit mln vs disclos manag first
announc transact back april mln due mln
alloc corpor overhead pro rata share execut comp etc
separ legaci vet first choic asset merg hsic vet busi
creat show mln net loss nine month even though
investor believ net profit closer break-even believ also
incur extra sg cost prepar larger public compani etc
investor like get clariti analyst meet earli feb ahead
nevertheless upon subtract vet busi adjust mln
corpor overhead total compani earn power would reduc
current remain co earn power would reduc
current trade price-to-earnings publish
ep sinc spin-off remov faster-growth vet busi one could
theoriz remain co trade lower price-to-earnings current total
compani pre-spin howev given receiv bln dividend
worth price-to-earnings pt one could theoriz may still captur price-to-earnings post-spin
impli hypothet per share valuat post-spin contrast current use
price-to-earnings valu total today price-to-earnings post-spin impli valuat
provid full valuat matrix price-to-earnings rang figur
 valuat matrix pre- post-spin
pe pre-spin ep estimate impli pe remain co post-spin ep estimate impli dividend share valuat matrix mid-pt mid-pt epstax ratewil reflect offici offici offici offici updat ep earningson time bonu milon time bonu milon time bonu milon time bonu milequ ep impactequ ep impactequ ep impactequ ep ep mid singl digit ep mid singl digit ep mid singl digit ep mid singl digit rangebefor ep impactbefor ep impactbefor ep impactbefor ep impact barclay
steve valiquett herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli relat
specif recommend view express research report
barclay research produc invest bank barclay bank plc affili collect individu barclay
author contribut research report research analyst unless otherwis indic public date top report
reflect local time report produc may differ releas date provid gmt
avail disclosur
compani subject research report current import disclosur regard compani pleas refer
http //publicresearch barclay com altern send written request barclay research complianc seventh avenu floor
new york ny call
analyst respons prepar research report receiv compens base upon variou factor includ firm total
revenu portion gener invest bank activ profit revenu market busi
potenti interest firm invest client research respect asset class cover analyst
analyst regularli conduct site visit view materi oper cover compani barclay polici prohibit accept
payment reimburs cover compani travel expens visit
barclay research depart produc variou type research includ limit fundament analysi equity-link analysi
quantit analysi trade idea recommend contain one type barclay research may differ contain
type barclay research whether result differ time horizon methodolog otherwis
procedur pleas
http //publicresearch barcap com/s/rd htm order access barclay research conflict manag polici statement pleas refer
price sourc refinitiv last avail close price relev trade market unless anoth time sourc indic
